Last week, the FDA approved the first-ever oral medication, called Zurzuvae, to treat postpartum depression over the course of 14 days. JennaBreeTV
NORTH SALT LAKE — Rickie Bryner first experienced depression, anxiety, lack of appetite and intrusive thoughts after having her first child.
A childbirth educator and postpartum doula, Bryner has helped dozens of women work through their depression and heal. Until now, the only medication for postpartum depression was through an I.V. injection. Last week, the FDA approved the first-ever oral medication, called Zurzuvae, to treat postpartum depression over the course of 14 days.
“Mental health conditions are one of the leading causes of maternal death in our state," he said."A significant number of the maternal deaths that happen in our state happen there are associated with postpartum depression, so we're not adequately treating it. We need to be more aggressive.”
South Africa Latest News, South Africa Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
FDA approves first pill specifically designed to treat postpartum depressionFDA APPROVED: Doctors say postpartum depression is a condition that can start during pregnancy with symptoms such as feelings of sadness, guilt, loss of energy and difficulty sleeping.
Read more »
FDA Approves First Pill to Treat Postpartum DepressionThe FDA has approved a breakthrough pill for the treatment of postpartum depression. The pill, which takes effect in as little as three days, could be available for use by November. A recent study showed significant improvements in depressive symptoms for women taking a 50-milligram dose for two weeks.
Read more »
Volcanoes erupt differently than previously thought, scientists discoverA new study reveals that volcanoes within Earth's tectonic plates erupt due to carbon dioxide, not water, as previously believed. The magma originates from the Earth's mantle and is propelled upward by CO2.
Read more »
FDA Approves First Pill for Postpartum DepressionThe FDA has granted approval for the first pill to treat postpartum depression. The pill, called Zurzuvae, has shown significant improvement in depressive symptoms compared to a placebo group in a recent study. This is a major breakthrough as the only other approved therapy for postpartum depression is an expensive IV drug that requires long infusions in hospital settings.
Read more »
FDA Approves First Postpartum Depression Pill in the USIt’s estimated that each year in the U.S., more than 400,000 babies are born to mothers who are depressed. Without any treatment, postpartum depression can last for months or even years, according to the National Institute of Mental Health.
Read more »
Sage Therapeutics stock plunges 48% after FDA decision on postpartum depression drugThe FDA approved the pill Zuranolone, developed by Sage and Biogen, for postpartum depression but declined to approve it for major depressive disorder.
Read more »